{"id":6150,"date":"2022-11-29T04:32:44","date_gmt":"2022-11-29T04:32:44","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6150"},"modified":"2023-08-29T17:56:22","modified_gmt":"2023-08-29T17:56:22","slug":"incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6150","title":{"rendered":"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann"},"content":{"rendered":"<p>Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002<\/p>\n<p>ReneCann \u662f Incannex \u901a\u8fc7\u6536\u8d2d APIRx \u83b7\u5f97\u7684\u4f17\u591a\u5148\u8fdb\u7597\u6cd5\u4e4b\u4e00\uff0c\u8be5\u6536\u8d2d\u4e8e\u4eca\u5e74 8 \u6708\u5b8c\u6210\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5df2\u8058\u8bf7\u8de8\u56fd\u5408\u540c\u5f00\u53d1\u548c\u5236\u9020\u7ec4\u7ec7 Eurofins \u5f00\u59cb\u751f\u4ea7\u7ed3\u5408\u4e86\u5927\u9ebb\u915a\uff08CBG\uff09\u548c\u5927\u9ebb\u4e8c\u915a\uff08CBD\uff09\u7684\u72ec\u7279\u5916\u7528\u914d\u65b9\u3002<\/p>\n<p>\u6839\u636e Incannex \u7684\u8bf4\u6cd5\uff0cCBG \u662f\u4e00\u79cd\u5177\u6709\u5f3a\u5927\u6297\u708e\u7279\u6027\u7684\u7cbe\u795e\u6d3b\u6027\u5927\u9ebb\u7d20\u3002<\/p>\n<h2>\u6210\u529f\u7684\u4eba\u4f53\u7814\u7a76<\/h2>\n<p>ReneCann \u4e4b\u524d\u66fe\u5728\u8377\u5170\u7684 Maurits \u8bca\u6240\u8fdb\u884c\u8fc7\u4e34\u5e8a\u7814\u7a76\u3002\u4e16\u754c\u77e5\u540d\u76ae\u80a4\u79d1\u533b\u751f Marcus Meinardi \u535a\u58eb\u9886\u5bfc\u4e86\u4e3a\u671f\u516d\u5468\u7684\u8bd5\u9a8c\u3002<\/p>\n<p>\u8be5\u7814\u7a76\u8868\u660e\uff0c\u60a3\u6709\u6bcf\u79cd\u76ee\u6807\u76ae\u80a4\u75c5\uff08\u767d\u6591\u725b\u76ae\u7663\u548c\u6e7f\u75b9\uff09\u7684\u60a3\u8005\u7684\u75be\u75c5\u8bc4\u5206\u5747\u6709\u6240\u964d\u4f4e\u3002<\/p>\n<p>\u767d\u765c\u98ce\u60a3\u8005\u62a5\u544a\u75be\u75c5\u8bc4\u5206\u964d\u4f4e 10%\uff0c\u800c\u725b\u76ae\u7663\u60a3\u8005\u964d\u4f4e 33%\uff0c\u6e7f\u75b9\u60a3\u8005\u964d\u4f4e 22%\u3002<\/p>\n<p>\u201c\u7279\u522b\u662f\uff0c\u767d\u6591\u75c5\u60a3\u8005\u7684\u7ed3\u679c\u975e\u5e38\u4ee4\u4eba\u9f13\u821e\uff0c\u90e8\u5206\u539f\u56e0\u662f\u8be5\u75c5\u7684\u53d1\u75c5\u7387\u9ad8\u8fbe\u5168\u7403\u4eba\u53e3\u7684 0.5-1%\uff0c\u800c\u4e14\u6cbb\u7597\u65b9\u6cd5\u6709\u9650\uff0c\u201dIncannex \u8868\u793a\u3002<\/p>\n<p>\u5f53\u4ea7\u751f\u8272\u7d20\u7684\u7ec6\u80de\u505c\u6b62\u4ea7\u751f\u9ed1\u8272\u7d20\u65f6\uff0c\u5c31\u4f1a\u53d1\u751f\u767d\u765c\u98ce\u2014\u2014\u5bfc\u81f4\u6591\u5757\u4e2d\u7684\u76ae\u80a4\u989c\u8272\u6d88\u5931\u3002\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0c\u53d8\u8272\u533a\u57df\u901a\u5e38\u4f1a\u53d8\u5927\u3002<\/p>\n<p>\u5728\u4e34\u5e8a\u7814\u7a76\u4e2d\uff0cReneCann \u4e0e\u5f25\u6f2b\u6027\u518d\u8272\u7d20\u6c89\u7740\u76f8\u5173\uff0c\u7597\u6548\u6301\u7eed\u6570\u5468\uff0c\u6700\u7ec8\u5728\u8131\u8272\u590d\u53d1\u524d\u6301\u7eed\u6570\u5468\u3002<\/p>\n<h2>\u5927\u9ebb\u7d20\u7597\u6cd5<\/h2>\n<p>Incannex \u9996\u5e2d\u79d1\u5b66\u5b98 Mark Bleackley \u535a\u58eb\u8bf4\uff0cReneCann \u662f\u8be5\u516c\u53f8\u7b2c\u4e00\u4e2a\u542b\u6709 CBG \u7684\u4ea7\u54c1\uff0cCBG \u662f\u4e00\u79cd\u5c0f\u5927\u9ebb\u7d20\u3002<\/p>\n<p>\u201c\u6269\u5c55\u5230\u6b21\u8981\u5927\u9ebb\u7d20\u4f7f\u6211\u4eec\u6709\u673a\u4f1a\u5728\u4e00\u7cfb\u5217\u65b0\u7684\u6cbb\u7597\u9886\u57df\u63a2\u7d22\u8fd9\u79cd\u4e0d\u540c\u5206\u5b50\u5bb6\u65cf\u7684\u4e0d\u540c\u6d3b\u6027\u7279\u5f81\u3002\u201d<\/p>\n<p>Incannex \u6b63\u5728\u5f00\u53d1\u65b0\u578b\u836f\u7528\u5927\u9ebb\u548c\u8ff7\u5e7b\u7597\u6cd5\uff0c\u4ee5\u6cbb\u7597\u5927\u91cf\u672a\u6ee1\u8db3\u9700\u6c42\u7684\u75be\u75c5\u3002<\/p>\n<p>\u6b63\u5728\u79ef\u6781\u5f00\u53d1\u548c\u8fdb\u884c\u8bd5\u9a8c\u7684\u836f\u7269\u65e8\u5728\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24\u3001\u8111\u9707\u8361\u3001\u80ba\u90e8\u708e\u75c7\u3001\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3001\u708e\u75c7\u6027\u80a0\u75c5\u3001\u7126\u8651\u75c7\u548c\u6210\u763e\u75c7\uff0c\u4ee5\u53ca\u8bb8\u591a\u5176\u4ed6\u9002\u5e94\u75c7\u4e2d\u7684\u75bc\u75db\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002 ReneCann \u662f Incannex \u901a\u8fc7\u6536\u8d2d APIRx \u83b7\u5f97\u7684\u4f17\u591a\u5148\u8fdb\u7597\u6cd5\u4e4b\u4e00\uff0c\u8be5\u6536\u8d2d\u4e8e\u4eca\u5e74 8 \u6708\u5b8c\u6210\u3002 \u8be5\u516c\u53f8\u5df2\u8058\u8bf7\u8de8\u56fd\u5408\u540c\u5f00\u53d1\u548c\u5236\u9020\u7ec4\u7ec7 Eurofins \u5f00\u59cb\u751f\u4ea7\u7ed3\u5408\u4e86\u5927\u9ebb\u915a\uff08CBG\uff09\u548c\u5927\u9ebb\u4e8c\u915a\uff08CBD\uff09\u7684\u72ec\u7279\u5916\u7528\u914d\u65b9\u3002 \u6839\u636e Incannex \u7684\u8bf4\u6cd5\uff0cCBG \u662f\u4e00\u79cd\u5177\u6709\u5f3a\u5927\u6297\u708e\u7279\u6027\u7684\u7cbe\u795e\u6d3b\u6027\u5927\u9ebb\u7d20\u3002 \u6210\u529f\u7684\u4eba\u4f53\u7814\u7a76 ReneCann \u4e4b\u524d\u66fe\u5728\u8377\u5170\u7684 Maurits \u8bca\u6240\u8fdb\u884c\u8fc7\u4e34\u5e8a\u7814\u7a76\u3002\u4e16\u754c\u77e5\u540d\u76ae\u80a4\u79d1\u533b\u751f Marcus Meinardi \u535a\u58eb\u9886\u5bfc\u4e86\u4e3a\u671f\u516d\u5468\u7684\u8bd5\u9a8c\u3002 \u8be5\u7814\u7a76\u8868\u660e\uff0c\u60a3\u6709\u6bcf\u79cd\u76ee\u6807\u76ae\u80a4\u75c5\uff08\u767d\u6591\u725b\u76ae\u7663\u548c\u6e7f\u75b9\uff09\u7684\u60a3\u8005\u7684\u75be\u75c5\u8bc4\u5206\u5747\u6709\u6240\u964d\u4f4e\u3002 \u767d\u765c\u98ce\u60a3\u8005\u62a5\u544a\u75be\u75c5\u8bc4\u5206\u964d\u4f4e 10%\uff0c\u800c\u725b\u76ae\u7663\u60a3\u8005\u964d\u4f4e 33%\uff0c\u6e7f\u75b9\u60a3\u8005\u964d\u4f4e 22%\u3002 \u201c\u7279\u522b\u662f\uff0c\u767d\u6591\u75c5\u60a3\u8005\u7684\u7ed3\u679c\u975e\u5e38\u4ee4\u4eba\u9f13\u821e\uff0c\u90e8\u5206\u539f\u56e0\u662f\u8be5\u75c5\u7684\u53d1\u75c5\u7387\u9ad8\u8fbe\u5168\u7403\u4eba\u53e3\u7684 0.5-1%\uff0c\u800c\u4e14\u6cbb\u7597\u65b9\u6cd5\u6709\u9650\uff0c\u201dIncannex \u8868\u793a\u3002 \u5f53\u4ea7\u751f\u8272\u7d20\u7684\u7ec6\u80de\u505c\u6b62\u4ea7\u751f\u9ed1\u8272\u7d20\u65f6\uff0c\u5c31\u4f1a\u53d1\u751f\u767d\u765c\u98ce\u2014\u2014\u5bfc\u81f4\u6591\u5757\u4e2d\u7684\u76ae\u80a4\u989c\u8272\u6d88\u5931\u3002\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\uff0c\u53d8\u8272\u533a\u57df\u901a\u5e38\u4f1a\u53d8\u5927\u3002 \u5728\u4e34\u5e8a\u7814\u7a76\u4e2d\uff0cReneCann \u4e0e\u5f25\u6f2b\u6027\u518d\u8272\u7d20\u6c89\u7740\u76f8\u5173\uff0c\u7597\u6548\u6301\u7eed\u6570\u5468\uff0c\u6700\u7ec8\u5728\u8131\u8272\u590d\u53d1\u524d\u6301\u7eed\u6570\u5468\u3002 \u5927\u9ebb\u7d20\u7597\u6cd5 Incannex \u9996\u5e2d\u79d1\u5b66\u5b98 Mark Bleackley \u535a\u58eb\u8bf4\uff0cReneCann \u662f\u8be5\u516c\u53f8\u7b2c\u4e00\u4e2a\u542b\u6709 CBG \u7684\u4ea7\u54c1\uff0cCBG \u662f\u4e00\u79cd\u5c0f\u5927\u9ebb\u7d20\u3002 \u201c\u6269\u5c55\u5230\u6b21\u8981\u5927\u9ebb\u7d20\u4f7f\u6211\u4eec\u6709\u673a\u4f1a\u5728\u4e00\u7cfb\u5217\u65b0\u7684\u6cbb\u7597\u9886\u57df\u63a2\u7d22\u8fd9\u79cd\u4e0d\u540c\u5206\u5b50\u5bb6\u65cf\u7684\u4e0d\u540c\u6d3b\u6027\u7279\u5f81\u3002\u201d Incannex \u6b63\u5728\u5f00\u53d1\u65b0\u578b\u836f\u7528\u5927\u9ebb\u548c\u8ff7\u5e7b\u7597\u6cd5\uff0c\u4ee5\u6cbb\u7597\u5927\u91cf\u672a\u6ee1\u8db3\u9700\u6c42\u7684\u75be\u75c5\u3002 \u6b63\u5728\u79ef\u6781\u5f00\u53d1\u548c\u8fdb\u884c\u8bd5\u9a8c\u7684\u836f\u7269\u65e8\u5728\u6cbb\u7597\u963b\u585e\u6027\u7761\u7720\u547c\u5438\u6682\u505c\u3001\u521b\u4f24\u6027\u8111\u635f\u4f24\u3001\u8111\u9707\u8361\u3001\u80ba\u90e8\u708e\u75c7\u3001\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3001\u708e\u75c7\u6027\u80a0\u75c5\u3001\u7126\u8651\u75c7\u548c\u6210\u763e\u75c7\uff0c\u4ee5\u53ca\u8bb8\u591a\u5176\u4ed6\u9002\u5e94\u75c7\u4e2d\u7684\u75bc\u75db\u3002<\/p>\n","protected":false},"author":3,"featured_media":18419,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[33],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann<\/title>\n<meta name=\"description\" content=\"Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann\" \/>\n<meta property=\"og:description\" content=\"Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-29T04:32:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:56:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-Eurofins-Scientific-ReneCann-therapeutic-topical-application-immune-disorder-skin-diseases.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/\",\"name\":\"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-11-29T04:32:44+00:00\",\"dateModified\":\"2023-08-29T17:56:22+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann","description":"Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann","og_description":"Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/","og_site_name":"smallcapsCN","article_published_time":"2022-11-29T04:32:44+00:00","article_modified_time":"2023-08-29T17:56:22+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-Eurofins-Scientific-ReneCann-therapeutic-topical-application-immune-disorder-skin-diseases.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/","url":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/","name":"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-11-29T04:32:44+00:00","dateModified":"2023-08-29T17:56:22+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Incannex Healthcare (ASX: IHL) \u5c06\u5f00\u59cb\u751f\u4ea7\u5176 ReneCann \u6cbb\u7597\u836f\u7269\uff0c\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5b83\u5728\u514d\u75ab\u7cfb\u7edf\u75be\u75c5\u5f15\u8d77\u7684\u76ae\u80a4\u75c5\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u767d\u6591\u75c5\u3001\u725b\u76ae\u7663\u548c\u7279\u5e94\u6027\u76ae\u708e\uff08\u4e5f\u79f0\u4e3a\u6e7f\u75b9\uff09\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/incannex-healthcare-manufactures-renecann-immune-disordered-dermatological-conditions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Incannex Healthcare \u751f\u4ea7\u7528\u4e8e\u514d\u75ab\u7d0a\u4e71\u76ae\u80a4\u75c5\u7684 ReneCann"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6150"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6150"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6150\/revisions"}],"predecessor-version":[{"id":16029,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6150\/revisions\/16029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18419"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}